INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 216 filers reported holding INOVIO PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 1.57 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,780 | -13.0% | 20,000 | 0.0% | 0.00% | – |
| Q2 2023 | $8,940 | -46.8% | 20,000 | -2.4% | 0.00% | – |
| Q1 2023 | $16,810 | -47.4% | 20,500 | 0.0% | 0.00% | – |
| Q4 2022 | $31,980 | -11.2% | 20,500 | -0.7% | 0.00% | – |
| Q3 2022 | $36,000 | 0.0% | 20,650 | -1.9% | 0.00% | – |
| Q2 2022 | $36,000 | -51.4% | 21,050 | +0.7% | 0.00% | – |
| Q1 2022 | $74,000 | -28.2% | 20,900 | 0.0% | 0.00% | – |
| Q4 2021 | $103,000 | -41.5% | 20,900 | -14.5% | 0.00% | – |
| Q3 2021 | $176,000 | -22.5% | 24,434 | 0.0% | 0.00% | – |
| Q2 2021 | $227,000 | +2.3% | 24,434 | +2.1% | 0.00% | – |
| Q1 2021 | $222,000 | +2.3% | 23,934 | -2.4% | 0.00% | – |
| Q4 2020 | $217,000 | -45.8% | 24,522 | -29.0% | 0.00% | – |
| Q3 2020 | $400,000 | -50.9% | 34,522 | +14.0% | 0.00% | -100.0% |
| Q2 2020 | $815,000 | +1016.4% | 30,290 | +213.4% | 0.00% | – |
| Q1 2020 | $73,000 | +284.2% | 9,666 | +79.0% | 0.00% | – |
| Q4 2019 | $19,000 | +90.0% | 5,400 | +3.8% | 0.00% | – |
| Q3 2019 | $10,000 | -37.5% | 5,200 | 0.0% | 0.00% | – |
| Q2 2019 | $16,000 | -20.0% | 5,200 | 0.0% | 0.00% | – |
| Q1 2019 | $20,000 | 0.0% | 5,200 | 0.0% | 0.00% | – |
| Q4 2018 | $20,000 | -28.6% | 5,200 | 0.0% | 0.00% | – |
| Q3 2018 | $28,000 | +40.0% | 5,200 | 0.0% | 0.00% | – |
| Q2 2018 | $20,000 | -16.7% | 5,200 | 0.0% | 0.00% | – |
| Q1 2018 | $24,000 | +9.1% | 5,200 | 0.0% | 0.00% | – |
| Q4 2017 | $22,000 | -85.7% | 5,200 | -78.5% | 0.00% | – |
| Q3 2017 | $154,000 | -6.1% | 24,200 | +15.2% | 0.00% | – |
| Q2 2017 | $164,000 | +23.3% | 21,000 | +5.0% | 0.00% | – |
| Q1 2017 | $133,000 | -8.9% | 20,000 | -4.8% | 0.00% | – |
| Q4 2016 | $146,000 | -53.9% | 21,000 | -38.4% | 0.00% | – |
| Q3 2016 | $317,000 | -0.9% | 34,100 | -1.3% | 0.00% | – |
| Q2 2016 | $320,000 | +52.4% | 34,566 | +43.4% | 0.00% | – |
| Q1 2016 | $210,000 | +180.0% | 24,100 | +119.1% | 0.00% | – |
| Q4 2015 | $75,000 | +17.2% | 11,000 | 0.0% | 0.00% | – |
| Q3 2015 | $64,000 | -28.9% | 11,000 | 0.0% | 0.00% | – |
| Q2 2015 | $90,000 | +9.8% | 11,000 | +10.0% | 0.00% | – |
| Q1 2015 | $82,000 | -15.5% | 10,000 | -4.8% | 0.00% | – |
| Q4 2014 | $97,000 | -10.2% | 10,500 | -4.5% | 0.00% | – |
| Q3 2014 | $108,000 | +1700.0% | 11,000 | +1733.3% | 0.00% | – |
| Q2 2014 | $6,000 | – | 600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Affinity Asset Advisors, LLC | 200,000 | $998,000 | 0.36% |
| Green Alpha Advisors, LLC | 72,647 | $363,000 | 0.24% |
| Skaana Management L.P. | 227,851 | $1,137,000 | 0.18% |
| SEVEN EIGHT CAPITAL, LP | 196,351 | $980,000 | 0.18% |
| Defender Capital, LLC. | 103,038 | $514,000 | 0.16% |
| Skaana Management L.P. | 206,300 | $1,029,000 | 0.16% |
| WASATCH ADVISORS LP | 4,926,125 | $24,581,000 | 0.10% |
| Parametrica Management Ltd | 16,183 | $81,000 | 0.08% |
| Cedar Brook Financial Partners, LLC | 54,500 | $272,000 | 0.07% |
| Hennion & Walsh Asset Management, Inc. | 274,703 | $1,371,000 | 0.07% |